EGFR and head and neck squamous cell carcinoma: However, there are controversial reports of EGFR act in tumorgenesis, Bossi et al. indicated that nuclear EGFR variation, EGFR phosphorylation and TGF-α level can be as predictive factors in patients with head and neck squamous cell carcinoma treated by EGFR inhibitor drugs (15).